Cogent Biosciences (COGT) Revenue (2017 - 2020)

Cogent Biosciences' Revenue history runs 4 years deep, the most recent figure standing at $312000.0 for Q3 2020.

• In Q3 2020, Revenue fell 69.41% year-over-year to $312000.0; the TTM figure through Dec 2020 stood at $7.9 million (down 65.02% YoY), while the FY2020 annual figure was $7.9 million, down 65.02% from the prior year.
• Revenue was $312000.0 for Q3 2020 at Cogent Biosciences, down from $528000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $15.3 million in Q4 2019 to a low of $312000.0 in Q3 2020.
• Historically, Revenue has averaged $3.2 million across 4 years, with a median of $2.1 million in 2017.
• The sharpest annual moves came in 2019 and 2020: Revenue jumped 301.79% in 2019, then tumbled 83.17% in 2020.
• A 4-year view of Revenue shows it stood at $2.1 million in 2017, then surged by 79.23% to $3.8 million in 2018, then surged by 301.79% to $15.3 million in 2019, then tumbled by 97.96% to $312000.0 in 2020.
• The last three Revenue figures came in at $312000.0 (Q3 2020), $528000.0 (Q2 2020), and $7.0 million (Q1 2020), per Business Quant data.